Boston Scientific plans to use the bulk of the $1 billion of the free cash flow it expects to generate this year on acquisitions, according to CFO Jeff Capello; also, Intuitive Surgical, Zoll hit 52-week highs; and analysts' ups and downs.

Boston Scientific (NYSE:BSX) plans to hoard most of the more than $1 billion in free cash flow it expects to generate this year so it can make acquisitions to boost its top line, CFO Jeff Capello told analysts last week.
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...